Abstract | BACKGROUND: OBJECTIVE: To present our experience with intravenous tirofiban infusion, in the form of a monotherapy as well as in addition to intra-arterial tirofiban, as a prophylactic, and as a rescue management for thrombus in patients who have undergone embolization with coils for ruptured intracranial aneurysms. METHODS: RESULTS: Thromboembolic formation during the procedure was detected in 25 cases. Intra-arterial tirofiban dissolved the thromboembolus under angiographic control after 10 or more minutes in 19 (76%) of 25 patients. Two intracranial hemorrhagic complications (increase in the extent of hematoma) occurred during the follow-up period. Two cases of other complications occurred: hematuria and perioral bleeding. CONCLUSION: Intravenous tirofiban, as a monotherapy or in addition to intra-arterial tirofiban for thrombotic complications, seems to be useful as a treatment for acute aneurysm. However, alternatives to tirofiban should be considered if an associated hematoma is discovered before a patient receives a tirofiban infusion.
|
Authors | Chang Hyo Yoon, Ho-Won Lee, Young Soo Kim, Sang Won Lee, Jeong A Yeom, Jieun Roh, Seung Kug Baik |
Journal | Neurosurgery
(Neurosurgery)
Vol. 82
Issue 1
Pg. 76-84
(Jan 01 2018)
ISSN: 1524-4040 [Electronic] United States |
PMID | 28419294
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 by the Congress of Neurological Surgeons |
Chemical References |
- Fibrinolytic Agents
- Tyrosine
- Tirofiban
|
Topics |
- Adult
- Aged
- Aneurysm, Ruptured
(diagnostic imaging, drug therapy)
- Embolization, Therapeutic
(methods)
- Female
- Fibrinolytic Agents
(administration & dosage)
- Follow-Up Studies
- Humans
- Infusions, Intra-Arterial
(methods)
- Infusions, Intravenous
- Intracranial Aneurysm
(diagnostic imaging, drug therapy)
- Male
- Middle Aged
- Retrospective Studies
- Tirofiban
- Treatment Outcome
- Tyrosine
(administration & dosage, analogs & derivatives)
|